Preoperative Bath in Patients Submitted to Hip Arthroplasty

February 26, 2019 updated by: Lucia Maciel de Castro Franco, Federal University of Minas Gerais

Preoperative Bath in Patients Submitted to Hip Arthroplasty: Randomized Clinical Trial

Clinical trial for prevention, randomized, controlled, blinded, parallel, with three arms which purpose is verify the effects of nursing intervention preoperative bathing with 4% chlorhexidine gluconate, 10% Povidone iodine (PVPI) and soap without antiseptic, for the prevention of surgical site infection (SSI) in patients undergoing hip arthroplasty.

Study Overview

Detailed Description

Despite the recommendation in several guidelines of preoperative bathing with 4% chlorhexidine gluconate as a measure for the prevention of SSI, there is no evidence in the literature that support this practice. The objective of this study is to evaluate the effect of nursing intervention: preoperative bath using 4% chlorhexidine gluconate solutions, 10% povidone iodine degermante or soap without antiseptic for the prevention of SSI in patients undergoing elective hip arthroplasty surgery. The specific objectives are to compare the incidence of SSI in the three interventions, to assess the most effective intervention for the prevention of surgical infection and to estimate the frequency of allergic reactions caused by the use of the solutions. Two intervention groups (4% Chlorhexidine gluconate and PVPI10%) and a control group (without antiseptic soap) composed of 52 patients undergoing hip arthroplasty in each group will be randomized to perform the baths in the period from may 2015 to june 2017. Before the intervention, nasal swabs will be collected of patients to investigate colonization by Staphylococcus aureus.

The expected result is lower ISC rate with the proposed measures.

Study Type

Interventional

Enrollment (Actual)

162

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brazil
        • Federal University of Minas Gerais

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be 18 or older;
  • Elective procedure of total hip arthroplasty
  • No report of infectious focus at the surgical site
  • Know to respond to the clinical signs of a surgical infection or having a person responsible with this ability
  • Do not be a nasal carrier of Staphylococcus aureus before surgery
  • Have access to fixed or mobile phone

Exclusion Criteria:

  • Patient treating surgical site infection
  • Emergency hip prosthesis surgery or orthopedic trauma
  • Nasal carriers of Staphylococcus aureus before surgery
  • Previous history of allergic reactions to the products used in the bat

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
SHAM_COMPARATOR: Bathing with 4% Chlorhexidine gluconate
Two baths with chlorhexidine using precise methods, including to scrubb the whole body with 50mL of undiluted solution, at night before surgery and the morning of surgery.
Cationic biguanide - antimicrobial action rubbing in the skin.
Other Names:
  • HiBiScrub
  • 4% Chlorhexidine degermante
EXPERIMENTAL: Bathing with10% PVPI degermante
Two baths with PVPI using precise methods, including to scrubb the whole body with 50mL of undiluted solution for each bath, at night before surgery and the morning of surgery.
Polymer soluble in water of iodine with polyvinylpyrrolidone (PVP) - antimicrobial action rubbing in the skin.
Other Names:
  • Betadine
  • 10% Povidone iodine degermante
ACTIVE_COMPARATOR: Bathing with soap without antiseptic.
Two baths with soap using precise methods, including to scrubb the whole body with 50mL of undiluted solution for each bath, at night before surgery and the morning of surgery.
Liquid soap with glycerin, neutral pH. Skin cleansing
Other Names:
  • Non-medicated soap
  • Soap

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infection of Surgical Site (SSI)
Time Frame: During the first 90 days after surgery
The infections that develop after the surgical procedure
During the first 90 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Allergic reactions
Time Frame: In the first hours after procedure
Adverse reaction to a given product
In the first hours after procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lúcia MC Franco, PhD student, Federal University of Minas Gerais

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2015

Primary Completion (ACTUAL)

January 1, 2018

Study Completion (ACTUAL)

March 1, 2018

Study Registration Dates

First Submitted

December 20, 2016

First Submitted That Met QC Criteria

December 21, 2016

First Posted (ESTIMATE)

December 22, 2016

Study Record Updates

Last Update Posted (ACTUAL)

February 28, 2019

Last Update Submitted That Met QC Criteria

February 26, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The study and the information provided will be confidential and used only for purposes of this research. Disclosure of information will be anonymous and in conjunction with the responses of a group of people, never individually.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Wound Infection

Clinical Trials on 4% Chlorhexidine gluconate

3
Subscribe